Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia(Shanghai Medical College of Fudan University), Lu Lu(Shanghai Medical College of Fudan University), Shibo Jiang(Shanghai Medical College of Fudan University), Tianlei Ying(Shanghai Medical College of Fudan University), Yun Zhu(Chinese Academy of Sciences), Shuwen Liu(Zhengzhou University), Yanling Wu(Shanghai Medical College of Fudan University), Wei Xu(Beijing Geriatric Hospital), Meiqin Liu, Qiaoshuai Lan(Chinese University of Hong Kong)
Cited by 759
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
|Signal Transduction and Targeted Therapy|2020|363